We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The XEC variant of Covid is quickly becoming the dominant strain of the winter, but the current vaccines may not be as ...

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $54.82 which represents a decrease of $-2.64 or -4.59% from the prior close of $57.46. The stock opened at $57.08 and touched a ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...